> this article is on breast cancer. since breast cancer and prostate
> cancer parallel each other. my question is this. is it possible.....
[quoted text clipped - 4 lines]
> pinpoint the treatment if RT was needed, with more radiation in that
> particular area instead of a general wide beam spread.
From: mycroft@cox.net (Steve Jordan)
On September 8, c palmer wrote:
this article is on breast cancer. since breast cancer and prostate
cancer parallel each other. my question is this. is it possible.....
after an RP and the psa starts to rise, to inject or orally take a drug
that would make the lymph nodes visible, so that a doctor would be able
to see them on the screen in order to get biopsy samples of the actual
lymph node. by doing so, maybe the information we get would help
pinpoint the treatment if RT was needed, with more radiation in that
particular area instead of a general wide beam spread.
(snip interesting article)
There is a misunderstanding evident in Curtis's last sentence that
should be put to rest.
Unless the rad onc is old-fashioned or in some backward country, a
"general wide beam spread" is *no part* of modern EBRT using Intensity
Modulated Radiation Therapy (IMRT).
That's what the IM part of IMRT is about.
In my case, not unusual by any means, the total gland dose was 76 Gy.
Pelvic lymph nodes received 45 Gy;
seminal vesicles received 55 Gy. IOW, it is common when using IMRT to
dose other anatomical features separately in addition to the prostate
gland.
Regards,
Steve J
=======hi steve - i thought i expressed myself, but again, maybe i was thinking
one thing and said another.
the article i posted was about assessing the risk of recurrence of
breast cancer. that by monitoring the lymph nodes, they have found
certain things take place that is always consistent before the cancer
starts growing. this is not the assessment for the original breast
cancer.
since we are talking about recurrence of cancer - not the original
treatment - which for the men, would have been the RP. when the psa
starts to rise and one does not have a prostate, so where's the cancer?
this is why they use a wide beam radiation pattern over the whole
prostate bed in hopes to killing anything there so that it doesn't get a
chance to get out of there and into the body and spread.
so, if the male with the prostate removed but still has his lymph nodes
still in place is where my thinking was.
by making them visible to the person who could do a biopsy, it would be
nice to know what area is showing signs of change before it goes
cancerous. at least that was my thoughts on the subject.
i don't know if this can even be done. i'm not a person who deals in
the biopsy and do not know the limitations of the equipment.
perhaps, cpw could shed some light on this.
~ curtis
knowledge is power - growing old is mandatory - growing wise is optional
"Many more men die with prostate cancer than of it. Growing old is
invariably fatal. Prostate cancer is only sometimes so."
http://community.webtv.net/PALMER_ENT/doc
Steve Jordan - 09 Sep 2005 16:38 GMT
On September 9, Curtis Palmer replied to my last message regarding IMRT:
> hi steve - i thought i expressed myself, but again, maybe i was thinking
> one thing and said another.
(snip)
Well, maybe I misconstrued Curtis's message. I thought he was referring to
the general EBRT procedure, but it appears now that his subject was
confined to the salvage radiation tx, only.
Thanks for the clarification.
Regards,
Steve J
ross lazarus - 10 Sep 2005 03:49 GMT
> since we are talking about recurrence of cancer - not the original
> treatment - which for the men, would have been the RP. when the psa
[quoted text clipped - 3 lines]
> prostate bed in hopes to killing anything there so that it doesn't get a
> chance to get out of there and into the body and spread.
Here's my 2c worth for whatever it's worth:
1. Breast cancer has a nasty reputation for early metastasis. Often via lymph vessels to axillary
and other chest nodes. Low gleason PCa appears to have less of this behaviour.
2. Local spread from PCa is unlikely if you had clear margins in the RP pathology - it doesn't tend
to jump locally AFAIK.
3. Spraying radiation around has potential adverse consequences like lymphoedema and lymphatic
malignancy so you'd hope for some serious benefits.
4. Bottom lines: AFAIK, for low grade PCa with clear RP margins, if you get a rise in PSA, you've
got metastases somewhere by definition. From memory, the conventional wisdom is that it's most
likely bone spread via blood (rather than lymph spread to lymph nodes typical of BCa). But I'm
remembering from a long time ago and there may be more recent evidence saying other things?